课题基金 / 基金详情

Study on the mechanism of vascular injury by novel species of advanced glycation endoproducts

Study on the mechanism of vascular injury by novel species of advanced glycation endoproducts
新型晚期糖基化内产物损伤血管机制研究
批准号:
14580645
负责人:
WATANABE Takuo
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

WATANABE Takuo的其他基金

相似基金

相关文献

中文摘要
翻译
在这项研究中,我们揭示了糖尿病患者血清中糖基化终产物(AGE)的新物种,其水平升高,确实与细胞受体RAGE结合并诱导细胞内信号。我们还鉴定了RAGE的一种新的剪接变体——内源性分泌型RAGE (esRAGE),并发现该变体对新型AGE物种诱导的血管损伤具有保护作用。此外,我们发现血清esRAGE水平与一些生活方式相关疾病的易感性之间存在显著相关。(1)我们证明了由牛血清白蛋白与甘油醛或乙醇醛培养产生的新型AGE物种,在表面等离子体共振法计算的类似解离常数下,与细胞RAGE强烈结合。(2)我们将新型AGEs与RAGE的结合区定位在RAGE的n端一个类似免疫球蛋白v结构域的区域。(3)我们证明了新的AGEs与RAGE的相互作用激活了MAP激酶信号通路,并诱导了培养的人内皮细胞中V cam - 1的表达。(4)我们建立了RAGE基因敲除小鼠,并证明在没有RAGE的情况下,糖尿病肾病的发展受到显著抑制。(5)我们从人内皮细胞中分离出一种新的RAGE剪接变体,该变体缺乏跨膜结构域,由细胞分泌,并将其命名为esRAGE(~内源性分泌型RAGE)。(6)此外,我们还发现,通过细胞外捕获RAGE lingads, esRAGE对新型AGEs诱导的血管损伤具有保护作用。(7)建立esRAGE ELISA系统,分析生活方式相关疾病患者血清esRAGE水平。然后我们发现血清esRAGE水平与一些生活方式相关疾病的易感性显著相关,提示。血清esRAGE水平可能是一些生活方式相关疾病的有用风险指标。
英文摘要
In this research, we revealed that the novel species of advance glycation endproducts (AGE), whose level in serum is elevated in diabetic patients, do bind to their cellular receptor RAGE and induce intracellular signals.We also identified a novel splicing variant of RAGE-endogenous secretory RAGE (esRAGE)-and found that this variant has protective effect against vascular injury induced by the novel AGE species. Moreover, we found the significant coirelation between serwn esRAGE level and susceptibility of some life-style related diseases.(1) We demonstrated that the novel AGE species, which is generated by incubating bovine serum albumin with glyceraldehyde or glycolaldehyde, strongly binds to cellular RAGE at comparable dissociation constants calculated by the suiface plasmon resonance method.(2) We mapped the binding region of the novel AGEs on RAGE at an inununoglobulin V-domain-like region on its N-terminal end.(3) We demonstrated that the interaction of the new AGEs to RAGE activated MAP kinase signaling pathway and induced V CAM-i expression in cultured human endothelialcells.(4) We created RAGE knockout mice and demonstrated that the development of diabetic nephropa thy was dramatically suppressed in the absence of RAGE..(5) We isolated a novel splicing variant of RAGE from human endothelial cells that lacks transmembrane domain and is secreted from cells, and termed this novel variant esRAGE (~ndogenous secretory RAGE).(6) Furthennore we found that esRAGE has a protective effect against the vascular injuly induced by the novel AGEs, by extracellular capture of the RAGE lingads.(7) We established esRAGE ELISA system and analyzed serum level of esRAGE in patients with life-style related deseases. Then we found significant correlation between serum esRAGE level and susceptibility of some life-style related diseases, suggesting that. the serum esRAGE level could be a useful risk marker for some life-style related deseases.
期刊论文(252)
专著(0)
科研奖励(0)
会议论文
Sakurai, S.: "Identification of a novel AGE-capturable soluble variant of the receptor for AGE in human sera."Excerpta Medica International Congress Series. 1245. 163-167 (2002)
Sakurai, S.:“人类血清中 AGE 受体的新型 AGE 可捕获可溶性变体的鉴定。”医学摘录国际大会系列。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okamoto, T.: "Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro."Biochem.Biophys.Res.Commun.. 297. 419-424 (2002)
Okamoto, T.:“英卡膦酸二钠在体外抑制晚期糖基化终产物诱导的血管生成。”Biochem.Biophys.Res.Commun.. 297. 419-424 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamamoto, Y.: "The role of AGE-RAGE system in the development of diabetic nephiopathy in vivo."Excerpta Medica International Congress Series 1245, The Maillard Reaction in Food Chemistry and Medical Science : Update for The Postgenomic Era(Horiuchi S, et
Yamamoto, Y.:“AGE-RAGE 系统在体内糖尿病肾病发展中的作用。”摘录国际医学大会系列 1245,食品化学和医学科学中的美拉德反应:后基因组时代的更新(Horiuchi S 等人)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okamoto, T.: "Incadronate disodium inhibits advanced glycation end products-induced angiogenesis in vitro."Biochein.Biophys.Res.Commun.. 297. 419-424 (2002)
Okamoto, T.:“英卡膦酸二钠在体外抑制晚期糖基化终产物诱导的血管生成。”Biochein.Biophys.Res.Commun.. 297. 419-424 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
81
    Specification Methods for Runtime Verification of Reflective Software
    • 批准号:
      24500033
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2012
    • 负责人:
      WATANABE Takuo
    • 依托单位:
    A novel signal reception mechanism by oligomerization of RAGE and gamma-secretase
    • 批准号:
      21590304
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      WATANABE Takuo
    • 依托单位:
    Safe Dynamic Composition and Secure Execution of Software Based on Static Analysis and Execution Monitoring
    • 批准号:
      17500017
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2005
    • 负责人:
      WATANABE Takuo
    • 依托单位:
    Research on Declarative Description and Consistency Checking of Policies for Adaptive Software
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: